Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New study pits two surgeries against each other for pelvic organ prolapse

NCT ID NCT06903988

Disease control Sponsor: Peking University People's Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study compares two surgical methods for treating pelvic organ prolapse, a condition where pelvic organs drop from their normal position. Researchers will randomly assign 86 women to receive either laparoscopic lateral suspension (a keyhole surgery) or transvaginal sacrospinous ligament fixation (a vaginal surgery). The goal is to see if the keyhole approach is as effective as the standard vaginal surgery at one year after the procedure.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
surgical procedure
What this could lead to
If successful, this could show that a less invasive laparoscopic surgery works as well as the standard vaginal surgery for treating pelvic organ prolapse.
What could go wrong
This is a small, single-center trial with only 86 participants, so results may not apply to everyone. Both surgeries carry risks like infection or recurrence.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 86 people

The number the study aims to enrol. It can still change while the study runs.

Started

Apr 2025

Expected to finish

Aug 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Age ≥ 18 years; 2. According to the POP-Q classification, patients who meet any of the following conditions: a. Patients with anterior wall prolapse of stage III or higher; b. Patients with apical prolapse of stage III or higher; 3. Patients who refuse conservative treatment or have ineffective conservative treatment and request surgical treatment for prolapse; 4. Patients who voluntarily participate in this study, sign the informed consent form, and are able to attend follow-up visits on time; 5. Patients who have received education at the primary school level or above; 6. Patients who are able to visit the hospital for examinations; 7. Patients who are deemed fit to undergo surgery according to preoperative anesthesia assessment. Exclusion Criteria: 1. Patients who have previously undergone surgery for pelvic organ prolapse (POP); 2. Patients with a history of anti-incontinence surgery or who are planned to undergo mid-urethral sling surgery for anti-incontinence during the current operation; 3. Patients who, after evaluation by the surgeon, have other conditions that affect eligibility for inclusion.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Pelvic organ prolapse (POP) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

pelvic organ prolapse

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Pelvic organ prolapse (POP)

Contacts and locations

Locations

  • Peking University People's Hospital

    Beijing, 100044, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.